BMI 0 3 0 3 B-clinical_variable
( 4 5 4 5 I-clinical_variable
body 5 9 5 9 I-clinical_variable
mass 10 14 10 14 I-clinical_variable
index 15 20 15 20 I-clinical_variable
) 20 21 20 21 I-clinical_variable
corresponding 22 35 22 35 O
to 36 38 36 38 O
equal 39 44 39 44 O
or 45 47 45 47 O
above 48 53 48 53 O
30 54 56 54 56 B-lower_bound
kg 57 59 57 59 I-lower_bound
/ 59 60 59 60 I-lower_bound
m^2 60 63 60 63 I-lower_bound
for 64 67 64 67 O
adults 68 74 68 74 O
by 75 77 75 77 O
international 78 91 78 91 O
cut 92 95 92 95 O
- 95 96 95 96 O
off 96 99 96 99 O
points1 100 107 100 107 O
and 108 111 108 111 O
equal 112 117 112 117 O
or 118 120 118 120 O
above 121 126 121 126 O
the 127 130 127 130 O
95th 131 135 131 135 B-lower_bound
percentile 136 146 136 146 I-lower_bound
for 147 150 147 150 O
age 151 154 151 154 B-age
and 155 158 155 158 O
sex 159 162 159 162 O
( 163 164 163 164 O
for 164 167 164 167 O
diagnosis 168 177 168 177 O
of 178 180 178 180 O
obesity 181 188 181 188 B-chronic_disease
) 188 189 188 189 O

Calcitonin 0 10 190 200 B-clinical_variable
equal 11 16 201 206 O
or 17 19 207 209 O
above 20 25 210 215 O
50 26 28 216 218 B-lower_bound
ng 29 31 219 221 I-lower_bound
/ 31 32 221 222 I-lower_bound
L 32 33 222 223 I-lower_bound

Confirmed 0 9 224 233 O
diagnosis 10 19 234 243 O
of 20 22 244 246 O
PWS 23 26 247 250 B-chronic_disease
( 27 28 251 252 I-chronic_disease
Prader 28 34 252 258 I-chronic_disease
- 34 35 258 259 I-chronic_disease
Willi 35 40 259 264 I-chronic_disease
Syndrome 41 49 265 273 I-chronic_disease
) 49 50 273 274 I-chronic_disease
( 51 52 275 276 O
by 52 54 276 278 O
genetic 55 62 279 286 O
testing 63 70 287 294 O
) 70 71 294 295 O

Family 0 6 296 302 O
or 7 9 303 305 O
personal 10 18 306 314 O
history 19 26 315 322 O
of 27 29 323 325 O
Multiple 30 38 326 334 B-cancer
Endocrine 39 48 335 344 I-cancer
Neoplasia 49 58 345 354 I-cancer
Type 59 63 355 359 I-cancer
2 64 65 360 361 I-cancer
( 66 67 362 363 I-cancer
MEN2 67 71 363 367 I-cancer
) 71 72 367 368 I-cancer
or 73 75 369 371 O
Medullary 76 85 372 381 B-cancer
Thyroids 86 94 382 390 I-cancer
Carcinoma 95 104 391 400 I-cancer
( 105 106 401 402 I-cancer
MTC 106 109 402 405 I-cancer
) 109 110 405 406 I-cancer

History 0 7 407 414 O
of 8 10 415 417 O
pancreatitis 11 23 418 430 B-chronic_disease
( 24 25 431 432 O
acute 25 30 432 437 O
or 31 33 438 440 O
chronic 34 41 441 448 O
) 41 42 448 449 O

Male 0 4 450 454 B-gender
or 5 7 455 457 I-gender
female 8 14 458 464 I-gender
, 14 15 464 465 O
age 16 19 466 469 B-age
at 20 22 470 472 O
the 23 26 473 476 O
time 27 31 477 481 O
of 32 34 482 484 O
signing 35 42 485 492 O
informed 43 51 493 501 O
consent 52 59 502 509 O

No 0 2 510 512 O
change 3 9 513 519 O
in 10 12 520 522 O
treatment 13 22 523 532 B-treatment
plan 23 27 533 537 O
with 28 32 538 542 O
growth 33 39 543 549 O
hormone 40 47 550 557 O
( 48 49 558 559 O
GH 49 51 559 561 O
) 51 52 561 562 O
from 53 57 563 567 O
randomisation 58 71 568 581 O
to 72 74 582 584 O
the 75 78 585 588 O
end 79 82 589 592 O
of 83 85 593 595 O
the 86 89 596 599 O
open 90 94 600 604 O
- 94 95 604 605 O
label 95 100 605 610 O
period 101 107 611 617 O
patients 108 116 618 626 O
on 117 119 627 629 O
growth 120 126 630 636 O
hormone 127 134 637 644 O
to 135 137 645 647 O
stay 138 142 648 652 O
on 143 145 653 655 O
, 145 146 655 656 O
patients 147 155 657 665 O
off 156 159 666 669 O
GH 160 162 670 672 O
to 163 165 673 675 O
stay 166 170 676 680 O
off 171 174 681 684 O
during 175 181 685 691 O
this 182 186 692 696 O
period 187 193 697 703 O
. 193 194 703 704 O
Adjustments 195 206 705 716 O
in 207 209 717 719 O
doses 210 215 720 725 O
of 216 218 726 728 O
growth 219 225 729 735 O
hormone 226 233 736 743 O
will 234 238 744 748 O
be 239 241 749 751 O
permitted 242 251 752 761 O
) 251 252 761 762 O

Stable 0 6 763 769 O
body 7 11 770 774 B-clinical_variable
weight 12 18 775 781 I-clinical_variable
during 19 25 782 788 O
the 26 29 789 792 O
previous 30 38 793 801 O
90 39 41 802 804 B-upper_bound
days 42 46 805 809 I-upper_bound
before 47 53 810 816 I-upper_bound
screening 54 63 817 826 O
( 64 65 827 828 O
below 66 71 829 834 O
10 72 74 835 837 B-upper_bound
kg 75 77 838 840 I-upper_bound
self 78 82 841 845 O
- 82 83 845 846 O
reported 83 91 846 854 O
weight 92 98 855 861 O
change 99 105 862 868 O
) 105 106 868 869 O

Suggestive 0 10 870 880 O
history 11 18 881 888 O
of 19 21 889 891 O
, 21 22 891 892 O
or 23 25 893 895 O
significant 26 37 896 907 O
risk 38 42 908 912 O
of 43 45 913 915 O
gastroparesis 46 59 916 929 B-chronic_disease
( 60 61 930 931 O
e.g. 61 65 931 935 O
marked 66 72 936 942 O
abdominal 73 82 943 952 O
bloating 83 91 953 961 O
post 92 96 962 966 O
meal 97 101 967 971 O
, 101 102 971 972 O
history 103 110 973 980 O
of 111 113 981 983 O
vomiting 114 122 984 992 O
, 122 123 992 993 O
severe 124 130 994 1000 O
constipation 131 143 1001 1013 O
) 143 144 1013 1014 O
, 144 145 1014 1015 O
as 146 148 1016 1018 O
judged 149 155 1019 1025 O
by 156 158 1026 1028 O
the 159 162 1029 1032 O
Investigator 163 175 1033 1045 O

Tanner 0 6 1046 1052 B-clinical_variable
stage 7 12 1053 1058 I-clinical_variable
1 13 14 1059 1060 O
for 15 18 1061 1064 O
part 19 23 1065 1069 O
B 24 25 1070 1071 O

Tanner 0 6 1072 1078 B-clinical_variable
stage 7 12 1079 1084 I-clinical_variable
2 13 14 1085 1086 B-lower_bound
- 14 15 1086 1087 O
5 15 16 1087 1088 B-upper_bound
pubertal 17 25 1089 1097 O
development 26 37 1098 1109 O
for 38 41 1110 1113 O
part 42 46 1114 1118 O
A 47 48 1119 1120 O

Testing 0 7 1121 1128 O
has 8 11 1129 1132 O
been 12 16 1133 1137 O
performed 17 26 1138 1147 O
to 27 29 1148 1150 O
evaluate 30 38 1151 1159 O
for 39 42 1160 1163 O
adrenal 43 50 1164 1171 B-chronic_disease
insufficiency 51 64 1172 1185 I-chronic_disease
and 65 68 1186 1189 O
documented 69 79 1190 1200 O
in 80 82 1201 1203 O
medical 83 90 1204 1211 O
record 91 97 1212 1218 O

Treatment 0 9 1219 1228 B-treatment
with 10 14 1229 1233 O
any 15 18 1234 1237 O
medication 19 29 1238 1248 B-treatment
prescribed 30 40 1249 1259 O
for 41 44 1260 1263 O
weight 45 51 1264 1270 B-clinical_variable
loss 52 56 1271 1275 O
within 57 63 1276 1282 O
90 64 66 1283 1285 B-upper_bound
days 67 71 1286 1290 I-upper_bound
before 72 78 1291 1297 I-upper_bound
screening 79 88 1298 1307 O
( 89 90 1308 1309 O
e.g. 90 94 1309 1313 O
orlistat 95 103 1314 1322 B-treatment
, 103 104 1322 1323 O
zonisamide 105 115 1324 1334 B-treatment
, 115 116 1334 1335 O
topiramate 117 127 1336 1346 B-treatment
/ 127 128 1346 1347 O
phentermine 128 139 1347 1358 B-treatment
, 139 140 1358 1359 O
lorcaserin 141 151 1360 1370 B-treatment
, 151 152 1370 1371 O
phentermine 153 164 1372 1383 O
, 164 165 1383 1384 O
bupropion 166 175 1385 1394 B-treatment
/ 175 176 1394 1395 O
naltrexone 176 186 1395 1405 B-treatment
, 186 187 1405 1406 O
liraglutide 187 198 1406 1417 B-treatment
, 198 199 1417 1418 O
metformin 200 209 1419 1428 B-treatment
) 209 210 1428 1429 O

Type 0 4 1430 1434 B-chronic_disease
1 5 6 1435 1436 I-chronic_disease
diabetes 7 15 1437 1445 I-chronic_disease
mellitus 16 24 1446 1454 I-chronic_disease
( 25 26 1455 1456 I-chronic_disease
T1DM 26 30 1456 1460 I-chronic_disease
) 30 31 1460 1461 I-chronic_disease

Type 0 4 1462 1466 B-chronic_disease
2 5 6 1467 1468 I-chronic_disease
diabetes 7 15 1469 1477 I-chronic_disease
mellitus 16 24 1478 1486 I-chronic_disease
( 25 26 1487 1488 I-chronic_disease
T2DM 26 30 1488 1492 I-chronic_disease
) 30 31 1492 1493 I-chronic_disease

Untreated 0 9 1494 1503 O
adrenal 10 17 1504 1511 B-chronic_disease
insufficiency 18 31 1512 1525 I-chronic_disease

